Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-02-27
2007-02-27
Wilson, James O. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S234800, C514S321000, C514S266220, C514S316000, C540S567000, C540S597000, C544S126000, C544S284000, C546S187000, C546S199000
Reexamination Certificate
active
10871522
ABSTRACT:
Piperidine-2,6-diones heterocyclically substituted in the 3-position corresponding to formula IAlso the production and use of such compounds in pharmaceutical formulations and related methods of treatment.
REFERENCES:
patent: 5618812 (1997-04-01), Castro Pineiro et al.
patent: 5665719 (1997-09-01), Bock et al.
patent: 6080742 (2000-06-01), Germann et al.
patent: 6656973 (2003-12-01), Cosenza
patent: 2004/0048859 (2004-03-01), Germann et al.
patent: 2004/0132716 (2004-07-01), Rudolf et al.
patent: 199 57 342 (2001-05-01), None
patent: 100 02 509 (2001-07-01), None
patent: WO 00/72836 (2000-12-01), None
An article by Giorgio Ttrinchieri entitled, “Interleukin-12: A Proinflammatory Cytokine with Immunoregulatory Functions that Bridge Innate Resistance and Antigen-Specific Adaptive Immunity,” Annual Review of Immunology 1995 13:251-76.
An article by Sylvie Trembleau et al entitled, “The Role of IL-12 in the Induction of Organic-Specific Autoimmune Diseases,” Immunology Today, vol. 16, No. 8 1995.
An article by Gabriele Mueller entitled, “IL-12 as Mediator and Adjuvant for the Induction of Contact Sensitivity in Vivo,” The Journal of Immunology, pp. 4661-4668, 1995.
An article by Markus F. Neurath et al, “Antibodies of the Interleukin 12 Abrogate Established Experimental Colitis in Mice,” The Journal of Experimental Medicine, vol. 182, Nov. 1995, pp. 1281-1290.
An article by Benjamin M. Segal et al entitled, “An Interleukin (IL)-10/IL-12 Immunoregulatory Circuit Controls Susceptibility to Autoimmune Disease,” The Journal of Experimental Medicine, vol. 187, No. 4, Feb. 16, 1998, pp. 537-546.
An article by Fiona Powrie entitled, “T Cells in Inflammatory Bowel Disease: Protective and Pathogenic Roles,” Immunity, vol. 3 pp. 171-174, Aug. 1995.
An article by Angelika Rudolphi et al entitled, “Polyclonal Expansion of Adoptively Transferred CD4+ αβ T cells in the Colonic Lamina Propria of Scid Mice with Colitis,” Eur. J. Immunol. 1996 26:1156-1163.
An article by Alexander H. Enk et al entitled, “Induction of Hapten-specific Tolerance by Interleukin 10 In Vivo,” J. Exp. Med. The Rockefeller University Press, 0022-1007/94/04/1397/06, vol. 179 Apr. 1994 pp. 1397-1402.
An article by David F. Fiorentino et al entitled, “IL-10 Acts on the Antigen-Presenting Cell to Inhibit Cytokine Production by Th1 Cells,” The Journal of Immunology, vol. 146 3444-3451, No. 10, May 15, 1991.
An article by Rene de Wall Malefyt et al entitled, “Interleukin 10(IL-10) Inhibits Cytokine Synthesis by Human Monocytes: An Autoregulatory Role of IL-10 Produced by Monocytes,” J. Exp. Med. The Rockefeller University Press, 0022-1007/91/11/1209/12, vol. 174, Nov. 1991, pp. 1209-1220.
An article by Herve Groux et al entitled, “A CD4+ T-cell Subset Inhibits Antigen-Specific T-cell Responses and Prevents Colitis,” Nature, vol. 389 Oct. 16, 1997, pp. 737-742.
An article by Soren Bregenholt et al entitled, “Increased Intracellular Th1 Cytokines in Scid Mice with Inflammatory Bowel Disease,” Eur. J. Immunol. 1998.28:379-389.
An article by Mario Clerici et al entitled, “Type 1/type 2 Cytokine Modulation of T-cell Programmed Cell Death as a Model for Human Immunodeficiency Virus Pathogenesis,” Proc. Natl. Acad. Sci., vol. 91, pp. 11811-11815, Dec. 1994.
An article by Jerome Estaquier et al entitled “T Helper Type 1/T Helper Type 2 Cytokines and T Cell Death: Preventative Effect of Interleukin 12 on Activation-Induced and CD95 (FAS/APO-1)-Mediated Apoptosis of CD4+T Cells from human Immunodeficiency Virus-Infected Persons,” J. Exp. Med. The Rockefeller University Press 0022-1007/95/12/1759/09, vol. 182 Dec. 1995 pp. 1759-1767.
An article by Elizabeth P. Sampaio et al entitled, “The Influence of Thalidomide on the Clinical and Immunologic Manifestation of Erythema Nodosum Leprosum,” The Journal of Infectious Diseases 1993: 168:408-14.
An article by Jeffrey M. Jacobson entitled, “Thalidomide for the Treatment of Oral Aphthous Ulcers in Patients with Human Immunodeficiency Virus Infection,” The New England Journal of Medicine, vol. 336, No. 21, pp. 1487-1493, 1997.
An article by Georgia Vogelsano et al entitled, “Thalidomide for the Treatment of Chronic Graft-Versus-Host Disease,” The New England Journal of Medicine, vol. 326, No. 16, pp. 1055-1058, 1992.
An article by Eli D. Ehrenpreis et al entitled, “Thalidomide Therapy for Patients With Refractory Crohn's Disease: An Open-Label Trial,” Gastroenterology, 1989; 117: 1271-1277.
An article by Eric Vasiliauskas et al entitled, “Open-Label Pilot Study of Low-Dose Thalidomide in Chronically Active, Steroid-Dependent Crohn's Disease,” Gastroenterology, 1999:117:1278-1287.
An article by Bernal et al entitled, “Cellular Immune Effects of Thalidomide in Actinic Prurigo,” , 1992, Int. J. Derm 31; 599.
An article by S. Rajkumar et al entitled, “Current Status of Thalidomide in the Treatment of Cancer,” Jul. 2001, Oncology, pp. 867-874.
An article by S. Singhal et al entitled, “Antitumor Activity of Thalidomide in Refractory Multiple Myeloma,” The New England Journal of Medicine, vol. 341, No. 21, pp. 1565-1609, 1999.
Buschmann Helmut Heinrich
Frosch Stefanie
Germann Tieno
Theil Fritz
Zimmer Oswald Karl
Gruenenthal GmbH
Truong Tamthom N.
Wilson James O.
LandOfFree
Piperidine-2,6-diones heterocyclically substituted in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperidine-2,6-diones heterocyclically substituted in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperidine-2,6-diones heterocyclically substituted in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3841852